Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 20, 2011 05:10 ET | Source: Ocera Therapeutics, Inc.

Tranzyme Pharma Ranked Number 54 Fastest Growing Company in North America on Deloitte's 2011 Technology Fast 500(TM)

RESEARCH TRIANGLE PARK, N.C., Oct. 20, 2011 (GLOBE NEWSWIRE) -- Tranzyme Pharma (Nasdaq:TZYM) today announced it ranked No. 54 on Deloitte's Technology Fast 500™, ranking of the 500 fastest...
October 19, 2011 05:10 ET | Source: Ocera Therapeutics, Inc.

Tranzyme Pharma to Present at the 10th Annual Bio Investor Forum

RESEARCH TRIANGLE PARK, N.C., Oct. 19, 2011 (GLOBE NEWSWIRE) -- Tranzyme Pharma (Nasdaq:TZYM), today announced that Vipin Garg, President and CEO, will present at the 10th Annual Bio Investor Forum...
October 18, 2011 05:10 ET | Source: Ocera Therapeutics, Inc.

Tranzyme Pharma Names Former Gilead Executive Franck Rousseau, M.D. Chief Medical Officer

RESEARCH TRIANGLE PARK, N.C., Oct. 18, 2011 (GLOBE NEWSWIRE) -- Tranzyme Pharma (Nasdaq:TZYM) today announced the appointment of Franck Rousseau, M.D. to the newly created position of Chief Medical...
October 05, 2011 05:10 ET | Source: Ocera Therapeutics, Inc.

Tranzyme Pharma Initiates Dosing in Phase 2b Trial of TZP-102 in Diabetic Patients With Gastroparesis

RESEARCH TRIANGLE PARK, N.C., Oct. 5, 2011 (GLOBE NEWSWIRE) -- Tranzyme Pharma (Nasdaq:TZYM), today announced that it has dosed its first patient in a Phase 2b, 12-week trial of its first-in-class,...
September 20, 2011 16:35 ET | Source: Ocera Therapeutics, Inc.

Tranzyme Pharma Appoints George Abercrombie to Its Board of Directors

RESEARCH TRIANGLE PARK, N.C., Sept. 20, 2011 (GLOBE NEWSWIRE) -- Tranzyme Pharma (Nasdaq:TZYM), today announced the appointment of George B. Abercrombie, R.Ph., M.B.A. to its Board of Directors and to...